Reding Andrew P. 4
4 · Precision Therapeutics Inc. · Filed Apr 3, 2018
Insider Transaction Report
Form 4
Reding Andrew P.
Director
Transactions
- Award
Stock Option (right to buy)
2018-03-31+4,546→ 4,546 totalExercise: $1.10From: 2018-03-31Exp: 2028-03-31→ Common Stock (4,546 underlying)
Holdings
- 53
Common Stock, $.01 par value